Hemolytic uremic syndrome due to sirolimus in a heart transplant recipient. Case report [2];Síndrome hemolítico-urémico en el transplante cardiaco producido por sirolimus. Descripción de un caso

Revista Espanola de Cardiologia

Volumn 60, Issue 1, 2007, Pages 85-86

  Izquierdo, María T ^a   Almenar, Luis ^a   Martínez Dolz, Luis ^a   Moro, José A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOSPORIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ADULT; ANEMIA; BLOOD TRANSFUSION; CASE REPORT; ECHOCARDIOGRAPHY; FEVER; GRAFT FAILURE; GRAFT RECIPIENT; HEART CARCINOMA; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; LETTER; MALE; PLASMAPHERESIS; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA;

EID: 33847614822     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(07)74992-8     Document Type: Letter

References (6)

1. Remuzzi G. Hus and TTP. Variable expression of a single entity. Kidney Int. 1997;32:292-308.
2. Mercadal L, Petitclerc T, Assogba U, Beaufils H, Deray G. Hemolytic and uremic syndrome after heart transplantation. Am J Nephrology. 2000;20:418-20.
3. Robson M, Cote I, Abbs I, Koffman G, Goldsmith D. Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentation of calcineurin-inhibitor-induced endotelial damage? Am J Transplant. 2003;3:324-7.
4. Reynolds JC, Agodoa LY, Yuan CM, Abbott KC. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis. 2003;42:1058-68.
5. Walder B, Ricou B, Suter PM. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation. J Heart Lung Transplant. 1998;17:1004-6.
6. Yakupoglu YK, Buell JF, Woodle S, Kahan BD. Individualization of immunosuppressive therapy III. Sirolimus associated with a reduced incidence of malignancy. Transplant Proc. 2006;38:358-61.